Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.34 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.32 |
| ▸ | SYK | P43405 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | PDE5A | O76074 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22155806 | 1.00 | ALOX5 (0.36) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL24825197 | 0.97 | ALOX5 (0.34) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL24887006 | 0.97 | ALOX5 (0.34) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL24888998 | 0.97 | PLA2G2A (0.37) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL22155752 | 0.96 | CYP1A1 (0.37) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL24826549 | 0.96 | CYP1A2 (0.35) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL24658142 | 0.95 | CYP1A1 (0.35) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL22155797 | 0.94 | CYP19A1 (0.36) | CYP1A1CYP1A2CYP1B1CYP19A1PRKDC | |
| SCHEMBL22155819 | 0.94 | ALOX5 (0.36) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 | |
| SCHEMBL22155750 | 0.94 | ALOX5 (0.36) | ALOX5CYP1A1CYP1A2CYP1B1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-11696497-B2 | Organic light emitting device | LG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11696497-B2 | Organic light emitting device | LG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| WO-2023287228-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-19 | — | — | WO | disclosed |
| US-20200203620-A1 | ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203620-A1 | ORGANIC LIGHT EMITTING DEVICE | MAP1LC3A, MAP1LC3C, MAP1LC3B | ALOX5 1093/4885CYP1A1 673/4885CYP1A2 1383/4885 |
| US-11696497-B2 | Organic light emitting device | MAP1LC3A, MAP1LC3C, MAP1LC3B | ALOX5 1093/4885CYP1A1 673/4885CYP1A2 1383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.